Lower mortality among stroke patients with schizophrenia: A nationwide population-based study

Psychosomatic Medicine

Volumn 73, Issue 1, 2011, Pages 106-111

  Kang, Jiunn Horng ^a   Xirasagar, Sudha ^b   Lin, Herng Ching ^c,d  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

mortality; schizophrenia; stroke

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; STROKE; STROKE PATIENT; SURVIVAL RATE; TAIWAN;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; MORTALITY; NATIONAL HEALTH PROGRAMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; STROKE; SURVIVAL RATE; TAIWAN;

EID: 78751639640     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181fdc2c9     Document Type: Article

References (47)

1. Burke TA, Venketasubramanian RN. The epidemiology of stroke in the East Asian region: a literature-based review. Int J Stroke 2006;1:208-15.
2. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-7.
3. Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC, Yip PK. Subtypes and case-fatality rates of stroke: a hospital-based stroke registry in Taiwan (SCAN-IV). J Neurol Sci 1998;156:220-6.
4. Lee WC, Joshi AV, Wang Q, Pashos CL, Christensen MC. Morbidity and mortality among elderly Americans with different stroke subtypes. Adv Ther 2007;24:258-68.
5. Protopsaltis J, Kokkoris S, Korantzopoulos P, Milionis HJ, Karzi E, Anastasopoulou A, Filioti K, Antonopoulos S, Melidonis A, Giannoulis G. Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke. Atherosclerosis 2009;203:228-35.
6. Suto Y, Nakayasu H, Maeda M, Kusumi M, Kowa H, Awaki E, Saito J, Nakashima K. Long-term prognosis of patients with large subcortical infarctions. Eur Neurol 2009;62:304-10.
7. Burroughs V, Weinberger J. Diabetes and stroke: part twotreating diabetes and stress hyperglycemia in hospitalized stroke patients. Curr Cardiol Rep 2006;8:29-32.
8. Freedman R. Schizophrenia. N Engl J Med 2003;349:1738-49.
9. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007;116:317-33.
10. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006;21:1133-7.
11. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000;283:506-11.
12. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull 1996;22:413-30.
13. Curkendall SM, Mo J, Glasser DB, Rose Stang M, Jones JK. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry 2004;65:715-20.
14. Lin HC, Hsiao FH, Pfeiffer S, Hwang YT, Lee HC. An increased risk of stroke among young schizophrenia patients. Schizophr Res 2008;101: 234-41.
15. Bar KJ, Letzsch A, Jochum T, Wagner G, Greiner W, Sauer H. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 2005;39: 519-27.
16. Chang JS, Yoo CS, Yi SH, Hong KH, Lee YS, Oh HS, Jung DC, Kim YS, Ahn YM. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progr Neuropsychopharmacol Biol Psychiatry 2010;34:924-9.
17. Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001;21:8-13.
18. Villareal RP, Liu BC, Massumi A. Heart rate variability and cardiovascular mortality. Curr Atheroscler Rep 2002;4:120-7.
19. Chen YH, Tsai SY, Lee HC, Lin HC. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med 2009;71:798-804.
20. Lin HC, Tsai SY, Lee HC. Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: a six-year follow-up study. J Affect Disord 2007;100:49-54.
21. Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St Sauver J. Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. Schizophr Res 2008;98:287-94.
22. Wood JB, Evenson RC, Cho DW, Hagan BJ. Mortality variations among public mental health patients. Acta Psychiatr Scand 1985;72:218-29.
23. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000;177:212-7.
24. Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ 2000;321:483-4.
25. Sundby J. Methodological considerations in the study of frequency, risk factors and outcome of reduced fertility. Scand J Soc Med 1989;17: 135-40.
26. Halliday GM. A review of the neuropathology of schizophrenia. Clin Exp Pharmacol Physiol 2001;28:64-5.
27. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of develop-mentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57: 637-48.
28. Henn FA, Braus DF. Structural neuroimaging in schizophrenia. An integrative view of neuromorphology. Eur Arch Psychiatry Clin Neurosci 1999;249 Suppl 4:48-56.
29. Himelhoch S, Leith J, Goldberg R, Kreyenbuhl J, Medoff D, Dixon L. Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. Gen Hosp Psychiatry 2009;31:30-2.
30. Globus MY, Ginsberg MD, Harik SI, Busto R, Dietrich WD. Role of dopamine in ischemic striatal injury: metabolic evidence. Neurology 1987;37:1712-9.
31. Haberg A, Qu H, Sonnewald U. Glutamate and GABA metabolism in transient and permanent middle cerebral artery occlusion in rat: importance of astrocytes for neuronal survival. Neurochem Int 2006;48: 531-40.
32. Hazell AS. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 2007;50:941-53.
33. Yulug B, Yildiz A, Guzel O, Kilic E, Schabitz WR, Kilic E. Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull 2006;69:656-9.
34. Yulug B, Bakar M, Ozan E. The neuroprotective effect of olanzapine. J Neuropsychiatry Clin Neurosci 2008;20:107-8.
35. Yulug B, Yildiz A, Hudaoglu O, Kilic E, Cam E, Schabitz WR. Olan-zapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull 2006;71:296-300. (Pubitemid 44750446)
36. Den Hertog HM, van der Worp HB, Tseng MC, Dippel DW. Cooling therapy for acute stroke. Cochrane Database Syst Rev 2009:1:CD001247.
37. Wang CX, Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 2007;24:537-46.
38. van der Kooij MA, Groenendaal F, Kavelaars A, Heijnen CJ, van Bel F. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia. Brain Res Rev 2008;59:22-33.
39. Writing Group Members, Lloyd-Jones D, Adams RJ, Brown TM, Car-nethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215.
40. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
41. Bogey RA, Geis CC, Bryant PR, Moroz A, O'Neill BJ. Stroke and neurodegenerative disorders. 3. Stroke: rehabilitation management. Arch Phys Med Rehabil 2004;85:S15-S20.
42. Chang KC, Tseng MC, Tan TY, Liou CW. Predicting 3-month mortality among patients hospitalized for first-ever acute ischemic stroke. J Formos Med Assoc 2006;105:310-7.
43. Chang KC, Tseng MC. Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 2003;34:e219-e221.
44. Appelros P. Prediction of length of stay for stroke patients. Acta Neurol Scand 2007;116:15-9.
45. Gioldasis G, Talelli P, Chroni E, Daouli J, Papapetropoulos T, Ellul J. In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece. Acta Neurol Scand 2008;118:268-74.
46. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health 2009;9:285.
47. John AP, Koloth R, Dragovic M, Lim SC. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Austr 2009;190:176-9.